minireview will attempt to summarize and evaluate these recent results as well as to draw comparisons with two other molecules that undergo similar patterns of proteolysis: sterol regulatory element binding protein (SREBP) and the ␤-amyloid precursor protein (APP).
ϩ -GV3) in which the DNA-binding are unknown.
domain of the yeast Gal4p and the transcriptional activaThe molecular mechanism by which Notch signaling tion domain of the viral protein VP16 are inserted just results in the transcriptional activation of downstream C-terminal to the transmembrane domain of full-length targets has remained mysterious. Deletion analyses of Notch. The authors find that expression of this construct Notch showed that intracellular fragments of Notch have in embryos results in transcription of a reporter gene constitutive activity and, to the surprise of many, localize under control of Gal4p-binding sites (also called UAS to the nucleus. These findings led Struhl et al. (1993) for upstream activation sequence). Their result demonand Lieber et al. (1993) to propose the proteolysis model strates that Gal4/VP16, though originally tethered to the of Notch signaling. The model states that ligand binding membrane by Notch, gains access to DNA in the nuresults in proteolytic cleavage of Notch and consequent cleus. The most plausible mechanism for this access is release of the Notch intracellular domain (NICD). The proteolysis to release the NICD and subsequent nuclear NICD then enters the nucleus and associates with CSL entry, as predicted by the proteolysis model. Struhl and proteins at target genes and activates transcription eiAdachi show, using a constitutively active form (N ECNther directly or indirectly through another factor such GV3) and two inactive forms of Notch (N Sev11 -GV3 and as CSL. N EGF -GV3), that the ability of the constructs to activate An alternative tethering model of Notch signaling was transcription of the reporter correlates with their ability proposed by Fortini and Artavanis-Tsakonas (1994) Both groups find that their full-length Notch-Gal4 contion that the NICD can function at very low levels by expressing an intracellular construct (Notch ICV1744 ) at sevstructs do not activate transcription of UAS reporters in embryos mutant for Delta, which encodes the embryonic eral expression levels, detecting this construct using the six-Myc tags, and assaying transcription from the Notch ligand. Lecourtois and Schweisguth show that transcriptional activation by Gal4-N fl still occurs in em-HES-1 promoter. The authors thereby show quantitatively that the NICD can indeed activate transcription at bryos mutant for the Notch downstream target E(spl), even though such embryos exhibit the same phenotype concentrations far below that detectable by conventional immunocytochemistry. as Delta mutant embryos. These results show that the inability of Gal4-N fl to activate transcription in Delta mu-A Role for Cytoplasmic/Transmembrane Proteolysis in Notch Signaling tant embryos is due directly to loss of Delta rather than to secondary effects due to loss of Notch signaling.
The genetic and biochemical results described above provide at best a strong correlation between Notch proStruhl and Adachi also rescue transcription of a UAS reporter in the absence of Notch signaling by expressing cessing and Notch signaling, but they do not provide functional evidence that proteolysis is required for sigDelta from a transgene at a time too late to rescue the Delta mutant phenotype.
naling. Schroeter et al. (1998) go on to provide such evidence. By N-terminal peptide sequencing, the auLecourtois and Schweisguth's experiment leaves open the possibility that the ability of the NICD to activate thors find that the NICD is produced by cleavage before a conserved valine residue that lies either within or just transcription, rather than its nuclear access, requires Delta. Since Struhl and Adachi's construct contains a C-terminal to the transmembrane domain. The authors proceed to generate a construct based on Notch ⌬E in VP16 activation domain and therefore does not require the transcriptional activation activity of the NICD, their which this conserved valine is replaced by a leucine or a lysine. This mutant construct, which contains the result demonstrates that nuclear access itself is dependent on Delta. These results are consistent with the transmembrane domain, exhibits reduced ability to drive expression from a HES-1 promoter as well as reduced prediction that proteolysis of Notch occurs only when the receptor is activated by binding its ligand Delta; it efficiency of NICD generation. In contrast, mutation of the cleavage site valine does not block the activity of a is still possible that ligand binding is also required for some other aspect of Notch activation. mNotch1 construct that does not contain a transmembrane domain (Notch ICV1744 ). This critical control demonBiochemical Evidence for Proteolysis to Release the Notch Intracellular Domain strates that the cleavage site valine is not required for activities of Notch once it has been released from the Kopan et al. (1996) present direct biochemical evidence that Notch is cleaved to release the NICD. The authors membrane and, taken with the authors' other results, upholds the prediction that blocking proteolysis blocks express in cultured mammalian cells a constitutively active form of mNotch1 in which the extracellular domain Notch signaling. The authors' findings are somewhat weakened, however, by the fact that they assay proteolis deleted but the transmembrane domain is left intact (Notch ⌬E ). The authors also replace the C-terminal ‫003ف‬ ysis and signaling in different cell types. The strong correlative evidence provided by all the amino acids of Notch with six Myc tags to increase the stability of the protein and to facilitate its detection.
above groups and the functional data provided by Schroeter et al. (1998) make a strong case for the proteThey observe that, even though Notch ⌬E possesses a transmembrane domain, it is detectable in cell nuclei by olysis model of Notch signaling. All groups, however, make use of artificial constructs and reporters, and critimmunocytochemistry. Western blot and pulse-chase analyses demonstrate that a 63 kDa peptide, which is ics will demand demonstration in vivo of ligand-dependent processing of wild-type Notch and its importance the size predicted for the NICD generated from their construct, is produced as a result of cleavage of Notch ⌬E for signaling. Such demonstration may be difficult, but the identification of the protease responsible for the cleavage will allow genetic experiments that address this issue.
Roles for Extracellular Proteolysis in Receptor Maturation and Notch Signaling
In addition to the cleavage to produce the NICD, cleavage also occurs in the Notch extracellular domain. Blaumueller et al. (1997) detect a ‫511ف‬ kDa membrane-associated fragment of mNotch2 on Western blots in addition to ‫003ف‬ kDa full-length mNotch2. The authors observe similar fragments of mNotch1 and Drosophila Notch. Based on its molecular weight, membrane association, and kinetics of generation, the authors conclude that this transmembrane fragment, which they term N TM , is produced by cleavage of Notch in the extracellular domain. By using various treatments to block vesicle trafficking, the authors demonstrate that this extracellular cleavage occurs in the trans-Golgi network. A ‫081ف‬ kDa peptide coimmunoprecipitates with N TM and is generated with the same kinetics as N TM , and the authors surmise that this peptide, which they name N EC , is the extracellular fragment of mNotch2 produced by the extracellular cleavage. The authors propose that the N TM /N EC heterodimer is the form of the Notch receptor that binds ligand, and in support of this hypothesis they show that cellular/transmembrane cleavage to release the NICD. Indeed, the Kopan group's Notch ⌬E construct, which lacks the extracellular domain, is constitutively cleaved, however (see Logeat et al., 1998) . It therefore remains possibly because it mimics a Notch molecule that has to be determined conclusively whether Kuz is required been cleaved at the second extracellular site.
for Notch processing or for some other aspect of Notch The Drosophila kuzbanian (kuz) gene appears to have signaling, whether Kuz cleaves Notch directly, and what a role in the extracellular cleavage of Notch. Animals in the relationship is between Kuz and furin. which kuz function is disrupted have Notch-like defects Models of Proteolysis: Notch, SREBP, and APP in lateral inhibition, cell-fate determination, axon guidIsraë l proposes a three-step model of Notch activation ance, and wing development. kuz encodes a metallopro-( Figure 1A ). The first step is proteolysis at the first extratease of the ADAM (a disintegrin and metalloprotease cellular site to produce the N TM /N EC heterodimer; this domain) family, and Kuz-like proteases have been found cleavage occurs in the trans-Golgi during receptor matin mouse (MKUZ) and C. elegans . Pan and uration and is catalyzed by furin. Ligand binding at the Rubin (1997) report that Drosophila embryos and culcell surface triggers the second step, cleavage at the tured cells in which Kuz activity is disrupted fail to prosecond extracellular site, which in turn triggers the third duce a ‫001ف‬ kDa fragment of Notch that may correstep, proteolysis at the transmembrane/intracellular site spond to N TM . Taken at face value, this result indicates to release the NICD. How ligand binding causes proteolthat Kuz is required for the first extracellular cleavage ysis and how proteolysis at the second extracellular site of Notch and presumably operates upstream of furin. This particular result of Pan and Rubin is controversial, triggers the cleavage to release the NICD are unknown.
This proteolysis model of Notch activation closely resince Notch receptor maturation requires proper intrasembles that described for SREBP (sterol regulatory cellular transport. element binding protein; for review, see Brown and Notch, SREBP, and APP may therefore share a patGoldstein, 1997). SREBP is an endoplasmic reticulum tern of a regulated extracellular cleavage that triggers protein with two transmembrane domains and undera transmembrane/intracellular cleavage. This shared goes two successive proteolytic cleavages ( Figure 1B) .
pattern and the role of the presenilins raise the excitProteolysis of SREBP in its luminal domain occurs in ing possibility of common components and processes response to low intracellular cholesterol levels and is shared by the three proteins. There may be differences activated by SREBP cleavage activating protein (SCAP) .
between the processing of the three proteins, however. This regulated proteolysis triggers a second cleavage For example, the two extracellular cleavages of Notch in the N-terminal transmembrane domain catalyzed by are proposed to be required in succession, while the two the S2P metalloprotease (Rawson et al., 1997) . As a extracellular cleavages of APP are mutually exclusive. result, the N terminus of SREBP is released from the Further research will reveal whether there are more simiendoplasmic reticulum membrane into the cytoplasm larities or differences between Notch, SREBP, and APP and translocates to the nucleus. Unlike the NICD, which processing. does not bind DNA and may activate transcription only Toward a More Complete Model of Notch Signaling indirectly, the SREBP N terminus is a bona fide transcrip-
The results summarized in this minireview provide a tion factor of the basic-helix-loop-helix class and binds basic skeleton for the proteolysis model of Notch activadirectly to target genes to activate their transcription.
tion. The challenge for researchers now is to confirm There are also similarities between the proposed proaspects of the model in vivo, to flesh out details of the cessing of Notch and that of the ␤-amyloid precursor model, to identify and assign functions to the molecules protein (APP). Three proteolysis events have been deinvolved in Notch signaling, and to integrate the model scribed for APP ( Figure 1C ; for review, see Selkoe, 1994) .
with previous work on Notch signaling. It also remains Proteolysis of APP in its extracellular domain by the soto be determined whether the proteolysis model is true called ␣-secretase activity generates a soluble form of for Notch signaling in all contexts, particularly those in APP (APP s ) that appears in some settings to be the which Notch signaling is independent of Su(H) or CBF1. bioactive form of APP. An alternative extracellular cleavage by the ␤-secretase activity, which in turn triggers Selected Reading cleavage in the transmembrane domain of APP by the ␥-secretase activity, generates the amyloid ␤ peptide,
